Market Capitalization (Millions $) |
221 |
Shares
Outstanding (Millions) |
21 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
6 |
Cash Flow (TTM) (Millions $) |
1 |
Capital Exp. (TTM) (Millions $) |
0 |
Bioplus Acquisition Corp
Bioplus Acquisition Corp is a special purpose acquisition company (SPAC) formed for the purpose of merging with or acquiring a company operating in the biotechnology or pharmaceutical sector. SPACs like Bioplus raise capital through an initial public offering (IPO) and then use those funds to acquire an existing company. As a result, the acquired company becomes publicly traded through the merger with the SPAC. Bioplus focuses specifically on the biotechnology and pharmaceutical industry, indicating its interest in driving innovation and advancements in healthcare through strategic acquisitions.
Company Address: 260 Madison Avenue New York 10026 NY
Company Phone Number: 287-4092 Stock Exchange / Ticker: NASDAQ BIOS
BIOS is expected to report next financial results on March 30, 2024. |
|
|